0001181431-11-048228.txt : 20110906
0001181431-11-048228.hdr.sgml : 20110905
20110906172600
ACCESSION NUMBER: 0001181431-11-048228
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110901
FILED AS OF DATE: 20110906
DATE AS OF CHANGE: 20110906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norton David Y
CENTRAL INDEX KEY: 0001529193
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 111076538
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER BLVD.
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
3
1
rrd321346.xml
FORM 3
X0204
3
2011-09-01
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001529193
Norton David Y
ONE TOWER CENTER BLVD.
FLOOR 14
EAST BRUNSWICK
NJ
08816
1
0
0
0
Common Stock, $0.01 par value
7249
D
Option to purchase Common Stock, $0.01 par value
4.01
2011-11-26
2021-09-01
Common Stock, $0.01 par value
9505
D
The right to receive these shares is pursuant to a restricted stock unit grant, 100% of which shall vest 30 days from the first anniversary of the grant date.
These stock options will vest as follows: 3,073 on November 26, 2011, 3,216 on February 26, 2012, and 3,216 on the earlier of May 26, 2012 or the Company's 2012 Annual Meeting of Stockholders.
Irina Ishak as Attorney-In-Fact for David Y. Norton
2011-09-06